Countries Taiwan

MLB Receives FDA Approval for TML-6 IND Application to Treat Alzheimer's Disease

MLB (Merry Life Biomedical Company, Ltd., Taiwan )  a biomedical company, announced that  the U.S. Food and Drug Administration (FDA) h...

 June 07, 2024 | News

Wistron and imedtac Collaborate with CMUH to Promote Advanced Medical Solutions in Malaysia

China Medical University Hospital (CMUH, Taiwan) and the Malaysian International Medical University (IMU), the first and top private medical and heal...

 June 03, 2024 | News

Formosa Pharmaceuticals Strikes Exclusive Licensing Deal with Tabuk for Innovative Eye Surgery Drug in MENA

Taiwan-based Formosa Pharmaceuticals announced that the company has entered into an exclusive licensing agreement with Tabuk Pharmaceuticals Manufacturing ...

 May 10, 2024 | News

CMUH and Microsoft Azure Introduce "gHi System" for AI-Assisted Medical Documentation

China Medical University Hospital (CMUH) and Microsoft Taiwan announced the Generative Healthcare Intelligent (gHi) System, which is being applied to ...

 April 03, 2024 | News

Roche Taiwan Joins Forces with TTY Biopharm, Ushering in a New Dawn for Cancer Care

Roche Taiwan has announced a pioneering partnership with TTY Biopharm Company Limited, aiming to broaden its influence in the fight against cancer in Taiwa...

 March 27, 2024 | News

BioGate Announces Breakthrough in Pancreatic Cancer Treatment with New Drug BGX

Under the leadership of Dr. Frank Huang, Chairman and CEO, BioGate disclosed that their in-house research and development team has engineered BGX by integr...

 March 07, 2024 | News

Caliway's CBL-514 Gains FDA Orphan Drug and Fast Track Designations for Dercum's Disease Treatment

Caliway Biopharmaceuticals (Caliway) announced that the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation (ODD) to CBL-514 for Dercum...

 March 05, 2024 | News

Synbio Tech's Probiotic TWK10 Earns Taiwan FDA Approval for Anti-fatigue Health Claim

Synbio Tech is thrilled to announce that its groundbreaking probiotic strain, Lactiplantibacillus plantarum TWK10, has been awarded a prestigious...

 February 19, 2024 | News

Acepodia Gains FDA Clearance for ACE2016, Initiates Phase 1 Study on Solid Tumor Treatment

This clearance marks a significant milestone for Acepodia, allowing the initiation of a Phase 1, first-in-human clinical trial to assess th...

 February 05, 2024 | News

Lumosa Therapeutics and CHI Memorial initiate a new Acute Stroke Study in Taiwan

Stroke, a leading cause of adult disability globally, hits particularly hard in Chattanooga, Tenn., an area known as the "Stroke Belt," with one of th...

 February 02, 2024 | News

Taiwan's Anbogen Secures $12.5M in Series A for Precision Oncology

The lead investor is China Development Industrial Bank (CDIB), with significant contributions from Taian Venture Capital, Maxpro and the National Developme...

 February 01, 2024 | News

Travere Therapeutics Licenses Sparsentan to Renalys Pharma for Japan, South Korea, Taiwan, and Southeast Asia

Travere Therapeutics,announced that it has entered into an exclusive licensing agreement with Renalys Pharma, Inc., to bring sparsentan, a dual endothelin ...

 January 29, 2024 | News

Caliway Receives Initial Approval for CBL-514 Phase 3 Fat Reduction Study

"We are all delighted to see CBL-514 showing its potential to become the new, promising, non-invasive fat reduction treatment in the previous Pha...

 January 24, 2024 | News

Bora Pharmaceuticals Expands Globally with $210 Million Acquisition of Upsher-Smith

BioPharma APAC Perspective: Bora's acquisition of Upsher-Smith for $210 million marks a pivotal moment for the pharmaceutical giant. This strategic move n...

 January 18, 2024 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close